about
The Promise of Preventive Cancer VaccinesHelicobacter pylori in humans: Where are we now?The Immunomodulator VacA Promotes Immune Tolerance and Persistent Helicobacter pylori Infection through Its Activities on T-Cells and Antigen-Presenting CellsHelicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications.Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategiesHelicobacter pylori research: historical insights and future directions.Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.The prevention of infection-associated cancersImmunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c miceAdvances in the management of gastric cancer.Bioactivity and immunological evaluation of LPS from different serotypes of Helicobacter pylori.In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori.Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype.Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces.Helicobacter pylori and its effect on innate and adaptive immunity: new insights and vaccination strategies.Guidelines for treatment of Helicobacter pylori in the East and West.The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.Helicobacter pylori: perspectives and time trends.Novel anti-Helicobacter pylori therapies.Use of probiotics in the fight against Helicobacter pylori.Immunology and vaccines and nanovaccines for Helicobacter pylori infection.The study of H. pylori putative candidate factors for single- and multi-component vaccine development.Comparison of Iron-Binding Ability Between Thr70-NapA and Ser70-NapA of Helicobacter pylori.Analysis of Genomic Diversity among Helicobacter pylori Strains Isolated from Iranian Children by Pulsed Field Gel Electrophoresis.The potential of dextran-based glycoconjugates for development of Helicobacter pylori vaccine.
P2860
Q26783742-8E3DB87E-C279-4D72-A4E3-60C8034D692CQ26825856-FD028A6D-BA35-43E8-806D-824B3341D448Q28067015-F5179E88-F143-4F06-BDE6-289F7EC01306Q33594856-1CC731F5-A34A-45F3-9697-BBC259150364Q34501728-DA94F2E5-CA71-4654-BD63-96CB28A3E749Q34764772-D7241402-2AE2-4004-BE4F-3A968F9C6523Q35096934-43C8B016-24A7-4A0B-8F17-F061177F289CQ35857515-629E9709-CA84-4C23-BCC7-0B43BB843FB9Q36120631-07F64DB1-FEF8-47DD-ADE1-E269A90F0A60Q36262343-E23CEA17-558D-4191-AB31-9A583C57DBD8Q36967967-2BAB1F3A-9CAD-43E1-B875-4D45ADFBAC80Q37043683-967D520D-0069-45D9-AF47-AB17C8705590Q37727194-D8B75918-A26E-42FD-9352-05837FB1D4C5Q37742184-B7D8A19F-D0AC-4848-869C-5AFA6B27F0D1Q37812388-E9E93AA2-FAAC-49E6-BD8F-5D6983CC024BQ37912220-53ABA12C-A6D7-4283-A988-60EB8E6DF6EDQ38225046-A67E7CE6-97AE-4ADC-AAFB-2BFD9A874217Q38227090-B94FC5D3-3C09-4815-B553-CCFB4CD1F1C2Q38257748-0EE24BB2-DFBD-459C-916D-BC4F832DD3BDQ38268663-A05D96C9-9BD2-40A8-ADB4-DD16C8F4B27AQ38341782-43983E78-0ECF-47BA-835E-6A153F1CDDF5Q39350897-E7D9E537-F6EE-4CCB-B095-C383CB5E2953Q41011366-C82E7756-FC22-49C4-A323-5E4A1FC112C8Q41032807-DB410D57-66A3-4069-92FB-5DD9DF183B19Q43652996-2001C715-8CED-4C75-A755-C4171E0327BD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of vaccines against Helicobacter pylori.
@en
Development of vaccines against Helicobacter pylori.
@nl
type
label
Development of vaccines against Helicobacter pylori.
@en
Development of vaccines against Helicobacter pylori.
@nl
prefLabel
Development of vaccines against Helicobacter pylori.
@en
Development of vaccines against Helicobacter pylori.
@nl
P2860
P356
P1476
Development of vaccines against Helicobacter pylori.
@en
P2093
Giuseppe Del Giudice
P2860
P304
P356
10.1586/ERV.09.62
P577
2009-08-01T00:00:00Z